AARP Urges 3rd Circ. To Revive Eye Drop Suit
AARP Inc. on Monday urged the Third Circuit to revive a class action accusing drug makers of boosting prescription eye drop sales by using bottles that dispensed higher than necessary doses,...To view the full article, register now.
Already a subscriber? Click here to view full article